Contrast-to-noise ratio in functional MRI of relative cerebral blood volume with sprodiamide injection

Journal of Magnetic Resonance Imaging

Volumn 7, Issue 3, 1997, Pages 523-527

  Lev, Michael H ^a   Kulke, Sarah F ^a   Sorensen, A Gregory ^a   Boxerman, Jerry L ^a   Brady, Thomas J ^a   Rosen, Bruce R ^a   Buchbinder, Brad R ^a   Weisskoff, Robert M ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Brain, blood flow; Magnetic Resonance, echo planar; Magnetic resonance, vascular studies; Magnetic resonance, volume measurement

Indexed keywords

DYSPROSIUM; NONIONIC CONTRAST MEDIUM; SPRODIAMIDE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAIN BLOOD VOLUME; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; IMAGE PROCESSING; IMAGE RECONSTRUCTION; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ANALYSIS OF VARIANCE; BLOOD VOLUME; BRAIN; BRAIN MAPPING; CONTRAST MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; PENTETIC ACID; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY;

EID: 0031403822     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.1880070312     Document Type: Article

References (24)

1. Rosen BR, Belliveau JW, Aronen HJ, et al. Susceptibility contrast imaging of cerebral blood volume: human experience. Magn Reson Med 1991; 22:293-299.
2. Aronen HJ, Gazit IE, Louis DN, et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994; 191:41-51.
3. Warach S, Li W, Ronthal M, Edelman RR. Acute cerebral ischemia: evaluation with dynamic contrast-enhanced MR imaging and MR angiography. Radiology 1992; 182:41-7.
4. Kurcharcyzk J, Vexler ZS, Roberts TP, et al. Echo-planar perfusion-sensitive MR imaging of acute cerebral ischemia. Radiology 1993; 188:711-717.
5. Belliveau JW, Kennedy DN, McKinstry RC, et al. Functional mapping of the human visual cortex by magnetic resonance imaging. Science 1991; 254:716-719.
6. Villringer A, Rosen BR, Belliveau JW, et al. Dynamic imaging with lanthanide chelates In normal brain: contrast due to magnetic susceptibility effects. Magn Reson Med 1988; 6:164-174.
7. Rosen BR, Belliveau JW, Vevea JM, Brady TJ. Perfusion imaging with NMR contrast agents. Magn Reson Med 1990; 14: 249-265.
8. Boxerman JL, Hamberg LM, Rosen BR, Weisskoff RM. MR contrast due to intravascular magnetic susceptibility perturbations. Magn Reson Med 1995; 34:555-566.
9. Rosen BR, Aronen HJ, Cohen MS, et al. Diffusion and perfusion fast scanning in brain tumors. In: Leeds NE, ed. Neuroimaging clinics of North America. Philadelphia: WB Saunders Company. 1993; 631-648.
10. Moseley ME, Vexler Z, Asgari HS, et al. Comparison of Gd-and Dy-chelates for T2* contrast-enhanced imaging. Magn Reson Med 1991; 22:259-264.
11. Weisskoff RM, Boxerman JL, Sorensen AG, Kulke SM. Campbell TA, Rosen BR. Simultaneous blood volume and permeability mapping using a single Gd-based contrast injection. In: Proceedings of the 3rd scientific meeting of the Society of Magnetic Resonance 1995. Nice, France: Society of Magnetic Resonance, 1995; 279.
12. Weisskoff R, Belliveau J, Kwong K, Rosen B. Functional MR imaging of capillary hemodynamics. In: Potchen E. ed. Magnetic resonance angiography: concepts and applications. St. Louis, MO: Mosby. 1992; 473-484.
13. Rocklage SM, Moseley ME, Kucharczyk J, Norman D, Quay SC. Early detection of perfusion deficits caused by regional cerebral ischemia in cats: T2-weighted magnetic susceptibility MRI using a nonionic dysprosium contrast agent. Invest Radiol 1990; 25:S37-S38.
14. Lai JJ, Jamleson GC. Determination of dysprosium in monkey serum by inductively-coupled plasma atomic emission spectrometry (ICP-AES) after the administration of sprodiamide injection, a new contrast medium for magnetic resonance imaging. J Pharm Biomed Anal 1993; 11:1129-1134.
15. Saeed M, Li HT, Wendland MF, Knollmann F, Higgins CB. Comparison of cardiovascular response to ionic and nonionic magnetic resonance susceptibility contrast agents. Invest Radiol 1994; 29:319-329.
16. Roberts TP, Kucharczyk J, Cox I, et al. Sprodiamide-injection-enhanced magnetic resonance imaging of cerebral perfusion. Phase I clinical trial results. Invest Radiol 1994; 29(suppl 2): S24-S26.
17. Aronen H, Boxerman J, Goldberg I, et al. Susceptibility contrast CBV mapping: optimization of contrast dose and imaging sequences. In: Proceedings of the 11th annual meeting of the Society of Magnetic Resonance in Medicine 1992. Berlin: Society of Magnetic Resonance in Medicine, 1992; 1129.
18. Dennie J, Sorensen AG, Weisskoff RM, Widner P. Kinsley-Harper L, Rosen BR. Hemodynamic imaging with Dy-DTPA-BMA in humans: direct comparison with Gd chelates. In: Proceedings of the 4th annual scientific meeting of the International Society for Magnetic Resonance in Medicine 1996. New York: International Society for Magnetic Resonance in Medicine, 1996; 1716.
19. Lev MH, Schaeffer PW, Sorensen AG, et al. Clinical utility of functional mri of cerebral blood volume in the evaluation of intracranial tumors. In: Proceedings of the 33rd annual meeting of the American Society of Neuroradiology 1995. Chicago: American Society of Neuroradiology, 1995; 36.
20. DeLaPaz RL, Ott IL, Paola T. Recurrent brain tumor versus radiation necrosis: comparison of MR relative cerebral blood volume maps and FDG PET. Chicago: Radiological Society of North America, 1995; 169.
21. Guckel F, Rempp K, Becker G, Kopke J, Loose R, Brix G. Nuclear magnetic resonance tomography as a functional diagnostic method. New approaches to non-invasive quantification of cerebral blood volume and blood flow. (In German.) Radiologe 1994; 34:619-626.
22. Leenders KL, Perani D, Lammertsma AA, et al. Cerebral blood flow, blood volume and oxygen utilization. Brain 1990; 113:27-47.
23. Fisel CR, Ackerman JL, Buxton RB, et al. MR contrast due to microscopically heterogeneous magnetic susceptibility: numerical simulations and applications to cerebral physiology. Magn Reson Med 1991; 17:336-347.
24. Lassen NA. Cerebral transit of an intravascular tracer may allow measurement of regional blood volume but not regional blood flow. J Cereb Blood Flow Metab 1984; 4:633-634.